The whole world of commodities in one App!

Watch Management & Expert Interviews, Site-Visit-Videos, News Shows and receive top and up to date Mining Information on your mobile device worldwide!

Download our unique App for free!
Commodity-TV Play Store
Commodity-TV App Store

Social Media

Pleasure and necessity

Increasing meat consumption and cultivated food products are a major issue, as is the legalisation of cannabis.

Receive up-to-date information about the company directly via push notification

Meat consumption is on the rise, especially in China, where there is a demand for beef. In Brazil, soybean farmers are struggling with the rising demand for pork. At the same time, the world population is growing and needs food. About 50 bathtubs full of water are needed to make a conventional steak. And animal production was responsible for 15 percent of greenhouse gases in 2018.

Cultivated products could counteract this. Up to 10,000 kilos of cultured meat can be produced from the cell sample of a donor animal. The first burgers produced in the laboratory were already presented in London in 2013. Whether such meat will prevail is still uncertain. 

There are also other interesting methods to treat food. For example, the Canadian EnWave - - has developed a method for dewatering materials. Fast, cost-effective drying has already led to numerous contracts with the food and pharmaceutical industries.

EnWave's technology has also found its way into the rapidly growing cannabis sector. EnWave earns money from licensing agreements with various companies and closed the third quarter of 2019 with record revenues. 

Cannabis companies are currently the focus of attention. The wave of legalization is rolling. And medical cannabis is also gaining more and more customers. In the cannabis industry, RavenQuest BioMed - - is a multi-business company. The cultivation of cannabis, which is particularly clean and safe for society, naturally plays an important role. RavenQuest BioMed's two production sites deliver top quality.

Current company information and press releases from RavenQuest BioMed ( and EnWave (

In accordance with §34 WpHG, I would like to point out that partners, authors and employees can hold shares in the companies mentioned in each case and therefore there is a possible conflict of interest. Only the German version of these messages applies.

Disclaimer: The information provided does not constitute any form of recommendation or advice. We expressly point out the risks involved in securities trading. No liability can be assumed for damages resulting from the use of this blog. I would like to point out that shares and in particular warrant investments are generally associated with risk. The total loss of the invested capital cannot be excluded. All information and sources are carefully researched. However, no guarantee is given for the correctness of all contents. I expressly reserve the right to make a mistake, in particular with regard to figures and exchange rates, despite the utmost care. The information contained herein has been obtained from sources believed to be reliable but does not claim to be accurate or complete. Due to court rulings the contents of linked external sites are also to answer for (so among other things district court Hamburg, in the judgement of 12.05.1998 - 312 O 85/98), as long as no explicit dissociation from these takes place. Despite careful control of the contents, I do not assume any liability for the contents of linked external sites. The respective operators are solely responsible for their content. The disclaimer of Swiss Resource Capital AG also applies: 

Always up to date with the newsletter from SRC

Swiss Resource Capital AG will use the information you provide in this form to keep in touch with you and to provide you with updates and marketing information. To receive our news, you still have to give us permission to send you E-Mails below.

You can change your mind at any time by clicking on the Unsubscribe link, which you can find in the footer of every email you receive from us, or by contacting us at [email protected] We will treat your information with care and respect. For more information about our privacy practices, visit our website. By clicking below, you agree that we may process your information in accordance with these Terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

* indicates required
SRC Mining & Special Situations ZertifikatSRC Mining & Special Situations Zertifikat